Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SmartX “Brain Supplement” Firm Should Rethink Its Product Claims – NAD

This article was originally published in The Tan Sheet

Executive Summary

Cerebral Success submitted studies that did not test SmartX products or similar formulas, but were limited to findings on separate ingredients. NAD also said even when using the disclaimer “designed to,” an advertiser must provide reasonable support a product will “deliver the touted benefits to consumers.”

You may also be interested in...



Hearing Supplement Improvement Claims Don't Echo Separate Ingredient Studies

National Advertising Division says Bel Marra Health's reliance on ingredient studies with dosage or usage that could not translate to the ingredients in the product failed to support its claims. “Without testing that the ingredients in the quantity found in Hearing Rescue have the claimed effect, the results from these studies cannot be used to support qualified claims that the same ingredients in the product reduce the damage caused by repeated noise exposure and improve hearing,” NAD said following a review from a challenge by the Council for Responsible Nutrition.

California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation

CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.

CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales

Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS107178

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel